Member of the Board
pharmaceutical industry
SPRINT BIOSCIENCE
Sweden
Karin Meyer is CEO of the Swedish Pharmaceutical Society. She has extensive experience in the pharmaceutical industry where she has worked with both research and development and business development. Before Karin Meyer joined the Swedish Pharmaceutical Society she was CEO of PCG Clinical Services AB, PCG Solutions AB and also the business manager at Uppsala University. Before that she worked for 10 years at Quintiles with clinical trials in Phase 1 and was more recently CEO of Quintiles Scandinavia. Karin Meyer has also worked at AstraZeneca in health economics in clinical trials and as administrator at the Medical Products Agency. She is also a member of the boards of several Life Science companies.
pharmaceutical industry